During 2023 MedVasc patent was granted in China, India, Canada, and Brazil.
MedVasc’s patent portfolio is strengthened by the progression relating to the company’s medical device, the anesthesia catheter SolutioTM. SolutioTM minimizes the pain when performing the gold standard treatment methods for treating varicose veins and is expected to reach the market in 2025.
“We note with pleasure that our patent is granted in all prioritized markets, it shows the strength of the patent. The company’s patent portfolio has already been granted in the US, Europe, Australia, South Africa, and Russia,” says Dr. Michael Åkesson, founder and board member of MedVasc.
MedVasc’s strong patent portfolio combined with a protected trademark worldwide creates good conditions for licensing and future development of additional medical applications.
